These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26456308)

  • 21. Comparison of unenhanced and gadoxetate disodium-enhanced spin-echo magnetic resonance imaging for the detection of experimental hepatocellular carcinoma in the rat.
    Goudemant JF; Van Beers BE; Demeure R; Grandin C; Delos M; Pringot J
    Invest Radiol; 1998 Feb; 33(2):80-4. PubMed ID: 9493722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
    Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
    AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
    Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
    AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: is it still reliable?
    Ringe KI; Gupta RT; Brady CM; Massey CM; Hahn A; Galanski M; Merkle EM; Lotz J
    Radiology; 2010 May; 255(2):451-8. PubMed ID: 20413758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging findings of primary hepatic angiosarcoma on gadoxetate disodium-enhanced liver MRI: comparison with hepatic haemangiomas of similar size.
    Kim B; Byun JH; Lee JH; Park BJ; Kwon HJ; Lee JH; Lee SJ; Won HJ; Shin YM; Kim PN
    Clin Radiol; 2018 Mar; 73(3):244-253. PubMed ID: 29111237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement patterns and pseudo-washout of hepatic haemangiomas on gadoxetate disodium-enhanced liver MRI.
    Kim B; Byun JH; Kim HJ; Won HJ; Kim SY; Shin YM; Kim PN
    Eur Radiol; 2016 Jan; 26(1):191-8. PubMed ID: 25933742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abdominal vasculature in dynamic contrast-enhanced liver MRI at 3.0T: an intraindividual comparative study using gadoxetate disodium and gadofosveset trisodium.
    Kupczyk PA; Willinek WA; Hadizadeh DR; Traeber F; Gieseke J; Meyer C; Schild HH; Kukuk GM
    Magn Reson Imaging; 2015 Dec; 33(10):1258-1266. PubMed ID: 26271178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI assessment of biliary ductal obstruction: is there added value of T1-weighted gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR cholangiography?
    Reiner CS; Merkle EM; Bashir MR; Walle NL; Nazeer HK; Gupta RT
    AJR Am J Roentgenol; 2013 Jul; 201(1):W49-56. PubMed ID: 23789696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging.
    Yamada A; Hara T; Li F; Fujinaga Y; Ueda K; Kadoya M; Doi K
    Radiology; 2011 Sep; 260(3):727-33. PubMed ID: 21712472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial.
    McClellan TR; Motosugi U; Middleton MS; Allen BC; Jaffe TA; Miller CM; Reeder SB; Sirlin CB; Bashir MR
    Radiology; 2017 Feb; 282(2):361-368. PubMed ID: 27509544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient Severe Motion Artifact Related to Gadoxetate Disodium-Enhanced Liver MRI: Frequency and Risk Evaluation at a German Institution.
    Well L; Rausch VH; Adam G; Henes FO; Bannas P
    Rofo; 2017 Jul; 189(7):651-660. PubMed ID: 28445909
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety of Gadoxetate Disodium for Hepatobiliary MRI in Children and Adolescents.
    Kim PH; Hwang JY; Choi YH; Yoon HM; Lee CW
    Radiology; 2024 Jun; 311(3):e232462. PubMed ID: 38860893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of incidence of acute transient dyspnea and related artifacts after administration of gadoxetate disodium: a prospective observational study.
    Grazioli L; Faletti R; Frittoli B; Battisti G; Ambrosini R; Romanini L; Gatti M; Fonio P
    Radiol Med; 2018 Dec; 123(12):910-917. PubMed ID: 30084108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computed Tomography Cholangiography Using the Magnetic Resonance Contrast Agent Gadoxetate Disodium: A Phantom Study.
    Dilger SKN; Nelson N; Venkatesh SK; Ehman EC; Fidler JL; Fletcher JG; McCollough CH; Yu L
    Invest Radiol; 2019 Sep; 54(9):572-579. PubMed ID: 31261292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
    Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
    Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Gadoxetate Disodium on Arterial Phase Respiratory Waveforms Using a Quantitative Fast Fourier Transformation-Based Analysis.
    Davenport MS; Malyarenko DI; Pang Y; Hussain HK; Chenevert TL
    AJR Am J Roentgenol; 2017 Feb; 208(2):328-336. PubMed ID: 27929673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of gadoxetate disodium-enhanced MR cholangiography in chronic cholestatic biliary disease.
    Kühn JP; Spoerl M; Nassif A; Mester M; Weitschies W; Siegmund W; Hosten N; Mensel B
    Clin Radiol; 2014 Oct; 69(10):1027-33. PubMed ID: 24957855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadolinium-Based Contrast Agents in Kidney Disease: Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists.
    Schieda N; Blaichman JI; Costa AF; Glikstein R; Hurrell C; James M; Jabehdar Maralani P; Shabana W; Tang A; Tsampalieros A; van der Pol C; Hiremath S
    Can Assoc Radiol J; 2018 May; 69(2):136-150. PubMed ID: 29706252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of hepatocellular phase imaging after intravenous gadoxetate disodium for assessing hepatic metastases from gastroenteropancreatic neuroendocrine tumors: comparison with other MRI pulse sequences and with extracellular agent.
    Tirumani SH; Jagannathan JP; Braschi-Amirfarzan M; Qin L; Balthazar P; Ramaiya NH; Shinagare AB
    Abdom Radiol (NY); 2018 Sep; 43(9):2329-2339. PubMed ID: 29470627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety profile of gadoxetate disodium in elderly patients (≥65 years).
    Endrikat J; Schwenke C; Vogtlaender K; Dohannish S; Breuer J
    Acta Radiol; 2018 Jan; 59(1):81-88. PubMed ID: 28372493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.